USV is fully equipped with state-of-the art equipment and qualified personnel to develop many large and small peptides/proteins of therapeutic interest by recombinant and chemical synthesis. We adopt novel ideas and innovative approaches to achieve our targets, which brings about products of an international quality.
USV has been successful in making Enterokinase (EK) by using a method based on recombinant DNA (rDNA) technology and Eptifibatide and Bivalirudin by chemical synthesis.